In vitro data suggest that BRD9 could be a treatment target in testicular germ cell tumours (TGCTs). Inhibition of BRD9 in TGCT cell lines reduced their viability.
Meta-analysis of Affymetrix microarray data and immunohistochemical analysis showed…
In vitro data suggest that BRD9 could be a treatment target in testicular germ cell tumours (TGCTs). Inhibition of BRD9 in TGCT cell lines reduced their viability.
Meta-analysis of Affymetrix microarray data and immunohistochemical analysis showed…